Ειδήσεις: DRUG APPROVAL | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

24/03 15:16 yahoo.com

Think Novo Nordisk Can't Keep Up in the GLP-1 Market? Its Latest Drug Approval Could Be a Game Changer

Novo Nordisk GLP‑1 drug approval diabetes treatment market competition innovation

24/03 13:27 yahoo.com

Truist Raises Vertex (VRTX) Price Target Following Phase 3 Trial Results

Vertex Pharmaceuticals Truist Securities price target Phase 3 trial biotech drug approval

24/03 12:21 thenextweb.com

Accumulus Technologies launches live integration layer between pharma systems and national drug regulators

Accumulus Technologies pharma integration drug approval regulatory network biotech global regulators

23/03 16:30 investing.com

Tarsus Pharmaceuticals shares rise on China drug approval milestone

Tarsus Pharmaceuticals China drug approval stock surge biotech regulatory milestone market reaction

19/03 18:21 statnews.com

STAT+: Novo Nordisk’s high-dose Wegovy approved in the U.S.

Novo Nordisk Wegovy high‑dose FDA voucher obesity treatment market share

19/03 18:21 statnews.com

STAT+: Novo Nordisk’s high-dose Wegovy approved in the U.S.

Novo Nordisk Wegovy high‑dose FDA voucher obesity treatment market share

Loading...